Avadel Pharmaceuticals plc - American Depositary Shares, each representing one Ordinary Share, nominal value $0.01 per share (AVDL)
CUSIP: 05337M104
Q3 2024 13F Holders as of 30 Sep 2024
- Type / Class
- Equity / American Depositary Shares, each representing one Ordinary Share, nominal value $0.01 per share
- Shares outstanding
- 98,762,388
- Total 13F shares
- 1,070,001
- Share change
- -5,955,013
- Total reported value
- $14,032,886
- Price per share
- $13.12
- Number of holders
- 5
- Value change
- -$83,726,145
- Number of sells
- 6
Quarterly Holders Quick Answers
What is CUSIP 05337M104?
CUSIP 05337M104 identifies AVDL - Avadel Pharmaceuticals plc - American Depositary Shares, each representing one Ordinary Share, nominal value $0.01 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 05337M104:
Top shareholders of AVDL - Avadel Pharmaceuticals plc - American Depositary Shares, each representing one Ordinary Share, nominal value $0.01 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Vivo Capital, LLC |
13F
|
Company |
4%
|
3,972,099
|
$55,847,712 | — | 30 Jun 2024 | |
| Tri Locum Partners LP |
13F
|
Company |
1.2%
|
1,189,518
|
$16,724,623 | — | 30 Jun 2024 | |
| MPM BioImpact LLC |
13F
|
Company |
0.79%
|
783,242
|
$11,012,383 | — | 30 Jun 2024 | |
| Knoll Capital Management, LLC |
13F
|
Company |
0.61%
|
600,000
|
$8,436,000 | — | 30 Jun 2024 | |
| David M. Knott Jr. |
13F
|
Individual |
0.34%
|
333,000
|
$4,682,000 | — | 30 Jun 2024 | |
| SCHULHOFF & CO INC |
13F
|
Company |
0.14%
|
137,000
|
$1,926,220 | — | 30 Jun 2024 | |
| Ameritas Investment Partners, Inc. |
13F
|
Company |
0.01%
|
9,055
|
$127,313 | — | 30 Jun 2024 | |
| 1620 INVESTMENT ADVISORS, INC. |
13F
|
Company |
0%
|
1,000
|
$14,060 | — | 30 Jun 2024 | |
| CWM, LLC |
13F
|
Company |
0%
|
99
|
$1,000 | — | 30 Jun 2024 | |
| HUNTINGTON NATIONAL BANK |
13F
|
Company |
0%
|
1
|
$16 | — | 30 Jun 2024 | |
| Douglas J. Williamson |
3/4/5
|
Chief Medical Officer |
—
class O/S missing
|
275,000
|
— | — | 14 Feb 2022 | |
| Richard J. Kim |
3/4/5
|
Chief Commercial Officer |
—
class O/S missing
|
147,000
|
— | — | 20 Feb 2024 |
Institutional Holders of Avadel Pharmaceuticals plc - American Depositary Shares, each representing one Ordinary Share, nominal value $0.01 per share (AVDL) as of Q3 2024
As of 30 Sep 2024,
Avadel Pharmaceuticals plc - American Depositary Shares, each representing one Ordinary Share, nominal value $0.01 per share (AVDL) was held by
5 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,070,001 shares.
The largest 5 holders included
Knoll Capital Management, LLC, Knott David M Jr, SCHULHOFF & CO INC, 1620 INVESTMENT ADVISORS, INC., and HUNTINGTON NATIONAL BANK.
This page lists
5
institutional shareholders reporting positions in this security
for the Q3 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2024 vs Q2 2024 Across Filers
Q2 2024 holders
10
Q3 2024 holders
5
Holder diff
-5
| Investor | Q2 2024 Shares | Q3 2024 Shares | Share Diff | Share Chg % | Q2 2024 Value $ | Q3 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.